Results 161 to 170 of about 209,238 (297)

Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides

European Journal of Heart Failure, EarlyView.
Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima, Desirée Wussler, Pedro Lopez‐Ayala, Maria Belkin, Albina Nowak, Xueting Lin, Ivo Strebel, Fabiana Sgueglia, Eleni Michou, Androniki Papachristou, Laureve Chollet, Codruta Popescu, Nikola Kozhuharov, Samyut Shrestha, Gabriela Kuster, Katharina Rentsch, Arnold Von Eckardstein, Mascha Binder, Felix Mahfoud, Tobias Breidthardt, Christian Mueller   +20 more
wiley   +1 more source

Papaverine use for radial artery sheath entrapment

Anatolian Journal of Cardiology, 2019
Alessandro Sciahbasi, Andrea Cuono, Alberto Marrangoni, Stefano Rigattieri   +3 more
doaj   +1 more source

Re: Primary PCI procedures during the COVID-19 pandemic: Global Experience

, 2020
Zdravko Babić, Eduard Margetić, Davor Miličić   +2 more
openalex   +1 more source

Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF‐CAP) in China

European Journal of Heart Failure, EarlyView.
Nationwide implementation of heart failure therapies in China. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; CV, cardiovascular; GDMT, guideline‐directed medical therapy; HF, heart failure; HF‐CAP, National Heart Failure Center Accreditation ...
Jingmin Zhou, Xuejuan Jin, Yamei Xu, Zhonglei Xie, Xiaotong Cui, Yanyan Wang, Hua Wang, Xinli Li, Yugang Dong, Yuhua Liao, Weimin Li, Alexandre Mebazaa, Jiefu Yang, Junbo Ge, on behalf of the Heart Failure Center Accreditation Program Investigators   +14 more
wiley   +1 more source

Optimizing the use of Indigenous high ash bituminous coal for sustainable pulverized coal injection and efficient energy transfer. [PDF]

Sci Rep
Karmakar A, Gopinathan P, Subramani T, Naik AS, Sethi MK, Santosh M, Sarkar P, Banerjee PK.   +7 more
europepmc   +1 more source

The Need for Re-evaluation of PCI Practice: from Proceduralists to Clinicians [PDF]

, 2019
Min Chul Kim, Youngkeun Ahn
openalex   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

European Journal of Heart Failure, EarlyView.
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi, Kevin Duarte, João Pedro Ferreira, Guillaume Baudry, Luca Monzo, John J.V. McMurray, Dirk J Van Veldhuisen, Bertram Pitt, Faiez Zannad, Nicolas Girerd   +9 more
wiley   +1 more source

Geographic variations and trends in percutaneous intervention for patients with and without acute myocardial infarction: A Japanese nationwide registry study. [PDF]

PLoS One
Saito Y, Mori Y, Yamaji K, Kohsaka S, Wada H, Ishii H, Amano T, Kobayashi Y, Kozuma K, J-PCI Registry Investigators.   +9 more
europepmc   +1 more source

Head‐to‐head comparison of TKI and CPI first‐line treatment strategies in advanced renal cell carcinoma—Real‐world data from the German research platform CARAT

International Journal of Cancer, EarlyView.
What's New? The current standard of care for locally advanced or metastatic renal cell carcinoma (aRCC) is either a combination of two immune checkpoint inhibitors (CPI) or a CPI plus a tyrosine kinase inhibitor (TKI). Here, the authors simulate a head‐to‐head trial comparing the real‐world effectiveness of these combination therapies with TKI ...
Peter J. Goebell, Martin Bögemann, Arnd Nusch, Viktor Grünwald, Lothar Müller, Eyck von der Heyde, Uwe M. Martens, Carolin Lennartz, Michaela Koska, Karin Potthoff, Anja Kaiser‐Osterhues, Carsten Grüllich, Michael Staehler, Martina Jänicke, Dominik Marschner, the CARAT Registry Group   +15 more
wiley   +1 more source

Ten-year target lesion failure in patients treated with primary PCI: results from DANAMI-3. [PDF]

Open Heart
Özbek BT, Islam U, Marquard JM, Kelbaek H, Kunkel JB, Holmvang L, Tilsted HH, Pedersen F, Koeber L, Hofsten D, Eftekhari A, Raungaard B, Bøttker HE, Terkelsen CJ, Christiansen E, Khalek IMA, Jensen LO, Engstrøm T, Lønborg JT.   +18 more
europepmc   +1 more source